Sat.Dec 14, 2024 - Fri.Dec 20, 2024

article thumbnail

How AI will reshape pharma by 2025

Drug Target Review

Artificial intelligence (AI) has revolutionised many industries, yet its adoption in pharmaceutical drug development has been notably slower. Concerns surrounding data security, the complexity of AI systems, and the rigorous regulatory frameworks in this field have caused the pharmaceutical industry to approach these technologies with caution. For years, AI and machine learning (ML) were often dismissed as little more than advanced statistics with little practical value in drug development.

article thumbnail

Keypoint Newsletter: Introducing the New Fellows Class of 2025

keypoint

Meet the Keystone Symposia Fellows Class of 2025, a stellar group of post-doctoral fellows and early-career scientists who will take part in this prestigious mentorship program.

Doctors 123
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can the heart heal itself? New study says it can

Science Daily: Pharmacology News

Physician-scientists found that a subset of artificial heart patients can regenerate heart muscle, which may open the door to new ways to treat and perhaps someday cure heart failure.

123
123
article thumbnail

Novo’s next-gen obesity drug misses expectations in closely watched trial

BioPharma Drive: Drug Pricing

Novo shares lost nearly a quarter of their value after an experimental combination treatment called cagrisema fell short of the bar set by executives.

Trials 117
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Could Olumiant Be A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful

Drugs.com

FRIDAY, Dec. 20, 2024 -- An existing drug might be able to treat an autoimmune disorder that causes dry eye, dry mouth, fatigue and muscle or joint pain. Baricitinib (Olumiant), a drug currently used to treat rheumatoid arthritis, appears to.

Disease 116
article thumbnail

Lycorine Suppresses Non‐Small‐Cell Lung Cancer Progression Through Activating STING Pathway and Stimulating an Antitumor Immune Response

Chemical Biology and Drug Design

Our results demonstrate the effects of LYD on cell viability, cell cycle, and apoptosis in NSCLC invitro and invivo models and explored its underlying mechanisms. Our findings suggest that LYD inhibited NSCLC cells growth by inducing G2/M arrest and subsequent apoptosis. It also inhibited the P70S6K and PS6 pathways. More interestingly, LYD also significantly activated the STING pathway in NSCLC, inducing CXCL10 and CCL5 expression, which may help overcome immunotherapy resistance.

More Trending

article thumbnail

Zepbound, Mounjaro shortages are resolved, FDA confirms

BioPharma Drive: Drug Pricing

The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a limited grace period before taking any enforcement actions.

article thumbnail

Study Supports Tamoxifen for DCIS Early Breast Cancers

Drugs.com

MONDAY, Dec. 16, 2024 -- The established hormone therapy drug tamoxifen can significantly decrease the risk of cancer recurring in women with an early, low-risk form of breast cancer, a new study says. Women who took tamoxifen after undergoing a.

Therapies 111
article thumbnail

Design, Synthesis and Pro‐Inflammatory Activity of Palmitoylated Derivatives of Thioglycolic Acid as New Immunomodulators

Chemical Biology and Drug Design

The new palmitoylated derivatives of thioglycolic acid are designed to mimic microbial lipopeptides as a new class of small-molecule immunomodulators. The most active compound ( 10 ) induced a 1226-fold increase in the expression of TNF- and IL-1 mRNA and triggered a marked release of NO in isolated macrophages at 1.0M. ABSTRACT The immune system is essential for the defense against infections and is critically implicated in various disorders, including immunodeficiency, autoimmunity, inflammati

article thumbnail

Carnivorous squirrels documented in California

Science Daily: Pharmacology News

California ground squirrels hunt, kill and eat voles, reveals a new study documenting evidence of widespread carnivorous behavior among squirrels.

116
116
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Merck calls quits on two immunotherapies for cancer

BioPharma Drive: Drug Pricing

The company is scrapping two drugs aimed at targets called TIGIT and LAG-3, both of which were in the middle of Phase 3 testing.

Drugs 111
article thumbnail

Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States

Drugs.com

FRIDAY, Dec. 20, 2024 -- An outbreak of salmonella linked to cucumbers has now been tied to 100 known cases of the illness across 23 states, the U.S. Food and Drug Administration reported Thursday. That's up from 68 cases reported in the FDA's last.

FDA 105
article thumbnail

Mollugin Derivatives as Anti‐Inflammatory Agents: Design, Synthesis, and NF‐κB Inhibition

Chemical Biology and Drug Design

The results of invivo anti-inflammatory tests showed that compound 5k was the most potent of the mollugin derivatives with an inhibition rate of 81.77%, which was significantly more potent than or the positive control drugs (ibuprofen and mesalazine). ABSTRACT Nuclear factor B (NF-B) is a key inducible transcription factor that controls a large number of genes involved in inflammatory and immune processes.

article thumbnail

Large Hadron Collider regularly makes magic

Science Daily: Pharmacology News

A brotherly research duo has discovered that when the Large Hadron Collider (LHC) produces top quarks -- the heaviest known fundamental particles -- it regularly creates a property known as magic.

Research 114
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Sanofi, Teva say study results show gut disease drug could be ‘best in class’

BioPharma Drive: Drug Pricing

Phase 2 results in inflammatory bowel disease hinted the therapy could be more potent than similar medicines from Merck and Roche, each of which were acquired in multibillion-dollar deals.

Disease 107
article thumbnail

Early Research Points to Possible New Parkinson's Drug

Drugs.com

THURSDAY, Dec. 19, 2024 -- Parkinson's is a relentless disease for which few treatments, and no real cure, exists. Now, researchers say they are on the trail of a potential new therapy for the disabling neurological illness.It's early research.

Research 105
article thumbnail

A Guide to Adaptive Randomisation in Clinical Trials

Quanticate

A randomised controlled clinical trial is the most prevalent design used in Phase II and Phase III clinical trials, whereby participants are randomly assigned to a control or experimental group with a fixed probability, normally 50% for each treatment. This is the gold standard [1] for identifying the best treatment within the trial with a large degree of certainty [2].

article thumbnail

Tinkering with the 'clockwork' mechanisms of life

Science Daily: Pharmacology News

Opening new doors for the development of nanotechnologies in medicine and other fields, scientists recreate and compare two natural mechanisms to better program the timescale of molecular communication and functionality.

114
114
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Roche sticks with Parkinson’s drug despite second study failure

BioPharma Drive: Drug Pricing

Even with another mid-stage setback, Roche believes there were enough positive signs to “merit further exploration” of the drug, which it’s been developing with Prothena for more than a decade.

Drugs 103
article thumbnail

Patient Hospitalized in Louisiana With First U.S. Case of Severe Bird Flu

Drugs.com

WEDNESDAY, Dec. 18, 2024 -- In a case first reported in Louisiana last Friday, a patient has now developed the first known case of bird flu so severe as to require hospitalization, according to the U.S. Centers for Disease Control and Prevention.

Hospitals 105
article thumbnail

The Importance of CDMO Flexibility: Adapting to the Ever-Changing Pharmaceutical Landscape

Drug Patent Watch

Flexibility has become more than just a buzzword it’s a necessity. Contract Development and Manufacturing Organizations (CDMOs) are at the forefront of this shift, playing a crucial role in bringing innovative therapies to market. But what exactly makes flexibility so important for CDMOs, and how can they cultivate this essential trait? Let’s dive into the world of pharmaceutical outsourcing and explore why adaptability is the key to success.

article thumbnail

Massive volcanic eruptions did not cause the extinction of dinosaurs

Science Daily: Pharmacology News

While volcanism caused a temporary cold period, the effects had already worn off thousands of years before the meteorite, the ultimate cause of the dinosaur extinction event, impacted.

114
114
article thumbnail

A Vertex partner — and potential rival — secures $100M to develop non-opioid pain drugs

BioPharma Drive: Drug Pricing

“Pain has really been out of favor in the industry up until very recently,” said John Mulcahy, SiteOne Therapeutics’ CEO. The company plans to use its new funds to get to “proof of concept” for its medicines.

Drugs 103
article thumbnail

California Declares Bird Flu Emergency as Outbreak in Cows Continues

Drugs.com

THURSDAY, Dec. 19, 2024 -- California Gov. Gavin Newsom declared a public health emergency on Wednesday as bird flu continues to spread among the states dairy cattle.This proclamation is a targeted action to ensure government agencies have the res.

article thumbnail

2025: Perspectives and Predictions From Advarra Thought Leaders

Advarra

2024 has been a year of growth and evolution in clinical research. The coming year is expected to be no different. As we look to 2025, Advarra thought leaders have compiled predictions and perspectives on key topics shaping the industry. These topics include perspectives on how artificial intelligence (AI) will be leveraged in clinical research, key regulatory trends shaping the industry, the movements of site consolidation, the continued challenges (and potential solutions) of study startup, an

article thumbnail

Antibody that neutralizes inhibitory factors involved in nerve regeneration leads to enhanced motor function after acute spinal cord injury

Science Daily: Pharmacology News

Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers have investigated this with promising results. For the first time, it was possible to identify patient groups that displayed a clinically relevant treatment effect.

Treatment 113
article thumbnail

Merck targets 2025 RSV season with antibody now under FDA review

BioPharma Drive: Drug Pricing

An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from respiratory syncytial virus.

FDA 94
article thumbnail

What's the Link Between Memory Problems and Sexism?

Drugs.com

FRIDAY, Dec. 20, 2024 -- Sexism is incredibly toxic to womens lives, resulting in lower pay, fewer career opportunities, worse health care and a greater risk of violence.It also can be toxic to their brain health, a new study says.U.S. women born i.

98
article thumbnail

Keypoint Newsletter: A Message from Our CEO

keypoint

Keystone Symposia CEO shares his first impressions, improvement and initiatives that will be implemented in 2025.

85
article thumbnail

Growing safer spuds: Removing toxins from potatoes

Science Daily: Pharmacology News

Scientists have discovered a way to remove toxic compounds from potatoes and tomatoes, making them safer to eat and easier to store. The breakthrough could cut food waste and enhance crop farming in extreme environments, like outer space.

110
110
article thumbnail

Effective Drug Patent Prosecution Strategies: Securing Your Pharmaceutical Innovations

Drug Patent Watch

Protecting your intellectual property is paramount. Drug patent prosecution is a complex and critical process that can make or break the success of a new medication. As a business professional in the pharmaceutical industry, understanding and implementing effective strategies for drug patent prosecution can be the difference between market domination and missed opportunities.

article thumbnail

Check Your Pantry, Lay's Classic Potato Chips Recalled Due to Milk Allergy Risk

Drugs.com

FRIDAY, Dec. 20, 2024 -- Holy chip! Frito-Lay has issued a limited recall of select 13-oz bags of Lays Classic Potato Chips due to the potential presence of undeclared milk, which could pose a serious health risk to individuals with a milk a.

98
article thumbnail

Keypoint Newsletter: December 2024

keypoint

Checkout the December 2024 Keypoint Newsletter for the latest news and views from Keystone Symposia, including Fellows spotlights, our new partership with the Endocrine Society, Women in Science networking events, emerging topics conferences and conference highlights.

Science 82